Ticker Scorecard - REPL Basics Company: Replimune Group, Inc. IPO Date: July 16, 2018 Sector: Healthcare Industry: Biotech Market Cap: $1.08B Activated in VL: True Average Daily Range Avg Daily Range: $0.59 | 3.14% Avg Daily Range (30 D): $0.39 | 3.07% Avg Daily Range (90 D): $0.37 | 2.95% Institutional Daily Volume Avg Daily Volume: .34M Avg Daily Volume (30 D): .61M Avg Daily Volume (90 D): .61M Trade Size Avg Trade Size (Sh.): 76 Avg Trade Size (Sh.) (30 D): 68 Avg Trade Size (Sh.) (90 D): 70 Institutional Trades Total Inst.Trades: 1,897 Avg Inst. Trade: $1.81M Avg Inst. Trade (30 D): $1.17M Avg Inst. Trade (90 D): $1.39M Avg Inst. Trade Volume: .12M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.81M Avg Closing Trade (30 D): $1.17M Avg Closing Trade (90 D): $1.39M Avg Closing Volume: 108.22K     News Nov 26, 2024 @ 4:55 AM Replimune Announces Pricing of Upsized Public Offe... Source: Globe Newswire Oct 23, 2024 @ 5:00 PM Non-melanoma Skin Cancer is Predicted to Exhibit R... Source: Delveinsight Oct 9, 2024 @ 8:01 PM Replimune Announces Inducement Grants Under Nasdaq... Source: N/A Sep 15, 2024 @ 1:45 PM Replimune Presents Primary Analysis Data from IGNY... Source: Replimune Group, Inc. Jul 30, 2024 @ 6:00 AM Anaveon appoints Dieter Weinand as Chair of its Bo... Source: Globe Newswire Financials   TTM Q3 2025 Q2 2025 Basic EPS $-3.07 $-.79 Diluted EPS $-3.07 $-.79 Revenue $ M $ M $ Gross Profit $ $ $ Net Income / Loss $ -228.24M $ -66.34M $ -53.06M Operating Income / Loss $ -241.06M $ -66.02M $ Cost of Revenue $ $ $ Net Cash Flow $ 74.64M $ $ PE Ratio     Splits Dec 01, 2010:   1:15